Skip to content

Clinical Evaluation of the RAVI-Guide

Clinical Evaluation of the Rapid Access Vitreal Injection Guide (RAVI-Guide)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02196584
Enrollment
55
Registered
2014-07-22
Start date
2014-08-31
Completion date
2016-06-30
Last updated
2016-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal Diseases

Brief summary

Hypothesis: The RAVI-Guide provides superior patient acceptability to the conventional lid speculum during intravitreal injections Aims: To compare patient acceptance and procedural complication rates of the RAVI-Guide with those of the conventional lid speculum and caliper approach

Interventions

None listed

Sponsors

Medical College of Wisconsin
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients age 18 years or older who undergo intravitreal injection for clinical indications.

Exclusion criteria

* Patients under the age of 18 years * Patients unable to give informed consent * Disorders that preclude the ability to judge pain or discomfort associated with intravitreal injection * Disorders that preclude the ability to assess for complications of intravitreal injection * Inability to assess the landmarks by which localization of intravitreal injection sites is determined, such as obscured corneal limbus * Inability to communicate directly to the physician and immediately after the procedure the level of pain or discomfort

Design outcomes

Primary

MeasureTime frameDescription
Pain severity associated with instrument type used for holding eyelids open during intravitreal injectionWithin 15 minutes of injection procedureA pain severity scale of 0 to 10, with 0 being no pain, and 10 being worst imaginable pain, will be used to grade pain severity.

Secondary

MeasureTime frameDescription
Procedural complications associated with instrument use during intravitreal injection procedureWithin 15 minutes of injection procedureA questionnaire that queries about procedural complications will be completed by the treating physician.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026